Interações medicamentosas
Betibeglogene autotemcel + Deferoxamine
Gravidade: Grave
Betibeglogene autotemcel and Deferoxamine: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Some iron chelators can suppress bone marrow and may interfere with engraftment and hematologic recovery after gene therapy conditioning. Chelation around the time of myeloablation and infusion is therefore restricted.
O que esta interação significa em palavras simples
Betibeglogene autotemcel and Deferoxamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Por que acontece
Potential additive myelosuppressive or marrow-impairing effects of chelators could compromise engraftment; deferoxamine itself is less myelosuppressive than some chelators, so the mechanism is not firmly established.
O que fazer
Stop iron chelation at least 7 days before conditioning, and avoid myelosuppressive chelators for about 6 months after infusion. Use phlebotomy or a non-myelosuppressive chelator if iron reduction is needed.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Betibeglogene autotemcel e Deferoxamine, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Deferoxamine
Perguntas frequentes
Can I take Betibeglogene autotemcel with Deferoxamine?
MediHelp rates the interaction as major. Betibeglogene autotemcel and Deferoxamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Some iron chelators can suppress bone marrow and may interfere with engraftment and hematologic recovery after gene therapy conditioning. Chelation around the time of myeloablation and infusion is therefore restricted.
How serious is the interaction between Betibeglogene autotemcel and Deferoxamine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop iron chelation at least 7 days before conditioning, and avoid myelosuppressive chelators for about 6 months after infusion. Use phlebotomy or a non-myelosuppressive chelator if iron reduction is needed.
What other medicines interact with Deferoxamine?
MediHelp also lists interactions of Deferoxamine with, for example, Ascorbic acid, Exagamglogene autotemcel, Lovotibeglogene autotemcel. The full list is on the Deferoxamine page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
